BA
The Boeing Company
BA has the edge over EML overall, supported by stronger valuation and stronger fundamentals.
EML
The Eastern Company
EML offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
EML Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Stable |
EML's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over EML in the historical PE scenario, which offers more potential upside but is not a forecast.
EML PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $16.97 | -45% |
| Fair | 14x | $25.80 | -16% |
| Current | 17x | $30.81 | — |
| Expensive | 21x | $37.74 | +23% |
Historical ranges are pointers, not guarantees.
EML's PE is in its expensive range at 17x.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
EML Forward outlook
There aren't enough analyst estimates for EML to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
EML Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.81 | +51% |
| Q2 2026 | $1.34 | +$2.70 |
| Q1 2026 | $0.96 | +$2.32 |
| Q4 2025 | $1.17 | +$2.54 |
| Q3 2025 | $1.20 | +$2.23 |
| Q2 2025 | -$1.36 | -171% |
| Q1 2025 | -$1.36 | -186% |
| Q4 2024 | -$1.37 | -200% |
EML has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over EML on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
EML Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $75M | +35% |
| Q2 2026 | $61.8M | -12% |
| Q1 2026 | $59.7M | -5.7% |
| Q4 2025 | $57.5M | -14% |
| Q3 2025 | $55.3M | -22% |
| Q2 2025 | $70.2M | -4.1% |
| Q1 2025 | $63.3M | -6.8% |
| Q4 2024 | $66.7M | -0.5% |
EML's revenue has held roughly level: $75M last quarter, up 35% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | +4.3 points |
| Q2 2026 | 2.7% | -1.8 points |
| Q1 2026 | 2.2% | -2.9 points |
| Q4 2025 | 3.8% | -0.7 points |
| Q3 2025 | 3.1% | -6.4 points |
| Q2 2025 | 4.5% | -2.9 points |
| Q1 2025 | 5.1% | +0.2 points |
| Q4 2024 | 4.5% | -3.5 points |
EML has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over EML on cash flow, with more consistent year-over-year improvement.
EML Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4M | -232% |
| Q2 2026 | $7.9M | +164% |
| Q1 2026 | $2.6M | +$5.3M |
| Q4 2025 | $1.5M | -83% |
| Q3 2025 | $3.1M | +$9.8M |
| Q2 2025 | $3M | -47% |
| Q1 2025 | -$2.7M | -250% |
| Q4 2024 | $9M | +62% |
EML usually generates cash, though not every quarter: the latest was −$4M, but it generated $8M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
EML Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -1.4K shares |
| 1 year | -0.9% | -54.2K shares |
| 3 years | -3.9% | -245K shares |
| 5 years | -3.9% | -243K shares |
| Available history | -3.8% | -241K shares |
EML has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $405,518 |
| Q1 2026 | $422,355 |
| Q4 2025 | $754,316 |
| Q3 2025 | $851,447 |
| Q2 2025 | $722,901 |
| Q1 2025 | $1.4M |
| Q2 2024 | $247,320 |
EML spent $2M buying back its own shares over the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
EML Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.2x | Healthy |
EML has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
EML Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 66.3 | Neutral |
EML's weekly RSI is 65 (neutral) and its Stochastic is 66 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
EML PE vs Industrials Sector
| Metric | EML | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 24x | 29% below |
| PE % | 67 | 58 | 9 pts above |
EML has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
EML Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.9 | 19% above |
| 20 week MA | $25.7 | 20% above |
| 50 week MA | $22.5 | 37% above |
| 100 week MA | $23.2 | 33% above |
| 200 week MA | $23.4 | 31% above |
EML has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
EML Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.0 | $24.6 | -18% |
| 2021 | $24.6 | $24.8 | +0.8% |
| 2022 | $24.8 | $20.3 | -18% |
| 2023 | $20.3 | $22.0 | +8.4% |
| 2024 | $22.0 | $26.6 | +21% |
| 2025 | $26.6 | $20.5 | -23% |
| 2026 YTD | $20.5 | $30.8 | +51% |
EML has the edge over BA on returns for 2026, with the stronger performance.